User profiles for Michael G Baker

Michael Baker

University of Otago
Verified email at otago.ac.nz
Cited by 21168

Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study

MG Baker, LT Barnard, A Kvalsvig, A Verrall, J Zhang… - The Lancet, 2012 - thelancet.com
Background Although the burden of infectious diseases seems to be decreasing in developed
countries, few national studies have measured the total incidence of these diseases. We …

[HTML][HTML] Successful elimination of Covid-19 transmission in New Zealand

MG Baker, N Wilson, A Anglemyer - New England Journal of …, 2020 - Mass Medical Soc
Elimination of Covid-19 Transmission in New Zealand In New Zealand, rapid, science-based
risk assessment linked to early, decisive government action was critical to containing Covid-…

[HTML][HTML] Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand

…, J Douglas, FK Mendes, A Sporle, MG Baker… - Nature …, 2020 - nature.com
New Zealand, a geographically remote Pacific island with easily sealable borders, implemented
a nationwide ‘lockdown’ of all non-essential services to curb the spread of COVID-19. …

[HTML][HTML] Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis

…, NJ Moreland, DA Williamson, MG Baker - PLoS neglected …, 2018 - journals.plos.org
Objective Antibiotic treatment of Group A Streptococcus (GAS) pharyngitis is important in
acute rheumatic fever (ARF) prevention, however clinical guidelines for prescription vary. GAS …

[HTML][HTML] Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic

…, A Kvalsvig, N Wilson, MG Baker - The Lancet Regional …, 2020 - thelancet.com
Approaches to preventing or mitigating the impact of the COVID-19 pandemic have varied
markedly between nations. We examined the approach up to August 2020 taken by two …

[HTML][HTML] Case-fatality risk estimates for COVID-19 calculated by using a lag time for fatality

…, A Kvalsvig, LT Barnard, MG Baker - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
We estimated the case-fatality risk for coronavirus disease cases in China (3.5%); China,
excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise …

Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases

MG Baker, N Wilson, T Blakely - bmj, 2020 - bmj.com
Michael Baker and colleagues argue that aiming for elimination of community transmission
of the SARS-CoV-2 virus could offer important advantages over a suppression or mitigation …

[HTML][HTML] Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

…, W Tapurau, L Emmerton, M Martin, MG Baker… - Nature …, 2021 - nature.com
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are
not currently recommended for pandemic influenza control. New Zealand used these NPIs …

[HTML][HTML] Global public health surveillance under new international health regulations

MG Baker, DP Fidler - Emerging infectious diseases, 2006 - ncbi.nlm.nih.gov
… Dr Baker is a public health physician and senior lecturer at the Wellington School of
Medicine and Health Sciences. He has worked as a short-term consultant to WHO during …

Home modifications to reduce injuries from falls in the home injury prevention intervention (HIPI) study: a cluster-randomised controlled trial

…, C Cunningham, M Cunningham, J Guria, MG Baker - The lancet, 2015 - thelancet.com
Background Despite the considerable injury burden attributable to falls at home among the
general population, few effective safety interventions have been identified. We tested the …